Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

François Mach

Clinical trials sponsored by François Mach, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a common blood thinner outsmart a hidden heart risk? Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Can a common blood thinner outsmart a hidden heart risk?

Disease control Not yet recruiting

About 1 in 5 people have genetically high levels of lipoprotein(a), a sticky fat that raises the risk of blood clots and heart disease. This pilot study asks whether one standard antiplatelet drug—aspirin or clopidogrel—is better at calming overactive platelets in these individua…

Sponsor: François MACH • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC